Epidemiology of Viral Hepatitis in the Indigenous Populations of the Arctic Zone of the Republic of Sakha (Yakutia)
Authors:
- Vera S. KichatovaVKVera S. Kichatova
- Maria A. LopatukhinaMLMaria A. Lopatukhina
- Ilya A. PotemkinIlya A. Potemkin
- Fedor A. Asadi MobarkhanFMFedor A. Asadi Mobarkhan
- Olga V. IsaevaOIOlga V. Isaeva
- Mikhail D. ChanyshevMCMikhail D. Chanyshev
- Albina G. GlushenkoAGAlbina G. Glushenko
- Kamil F. KhafizovKamil F. Khafizov
- Tatyana D. RumyantsevaTRTatyana D. Rumyantseva
- Sergey I. SemenovSSSergey I. Semenov
- Karen K. KyuregyanKKKaren K. Kyuregyan
- Vasiliy G. AkimkinVAVasiliy G. Akimkin
Open Access
- 25 February 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (3) , 464
Abstract
The indigenous populations of the Arctic regions of Russia experience the lowest coverage of health-related services. We assessed the prevalence of hepatitis A, B, C, D and E viruses (HAV, HBV, HCV, HDV and HEV) among 367 healthy adult Native people of the Arctic zone of Yakutia. The HAV seroprevalence was above and increased with age. The anti-HEV IgM and IgG antibody detection rates were 4.1% and 2.5%, respectively. The average HBsAg detection rate was 4.6%, with no positive cases identified in participants aged under 30 years, confirming the effectiveness of the newborn vaccination program that began in 1998. Anti-HDV antibodies were detected in 29.4% of HBsAg-positive cases. The anti-HCV and HCV RNA detection rates peaked in the age cohort of 50–59 years (10.8% and 3.9%). No statistically significant gender differences in the prevalence of different viral hepatitis were observed. The time-scaled phylogenetic analysis demonstrated that all HBV genotype A and D strains isolated in this study were autochthonous and had an estimated most common recent ancestor (MCRA) age of around the 11th to 14th century. Unlike HBV, the HCV strains of subtypes 1b, 2a and 2k/1b were introduced from other regions of Russia in the 1980s and 1990s. The HCV 1b sequence analysis revealed a series of transmission events. In conclusion, these data emphasize the urgent need for expanded viral hepatitis screening and care programs in the indigenous populations of the Arctic zone of Yakutia.Keywords
Funding Information
- Russian Science Foundation (ID-22-25-00549)
This publication has 34 references indexed in Scilit:
- Hepatitis E Virus Seroprevalence in Free-Ranging Deer in CanadaTransboundary and Emerging Diseases, 2016
- Hepatitis B Prevalence and Incidence in Greenland: A Population-Based Cohort StudyAmerican Journal of Epidemiology, 2015
- Genotypes and Genetic Variability of Hepatitis B VirusIntervirology, 2014
- Burden and prevention of viral hepatitis in the Arctic region, Copenhagen, Denmark, 22–23 March 2012International Journal of Circumpolar Health, 2013
- Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in TaiwanJournal of Clinical Microbiology, 2011
- Serologic Assays Specific to Immunoglobulin M Antibodies against Hepatitis E Virus: Pangenotypic Evaluation of PerformancesClinical Infectious Diseases, 2010
- Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5′ Untranslated Region SequencesJournal of Clinical Microbiology, 2007
- Distribution of Viral Hepatitis in Indigenous Populations of North America and the Circumpolar ArcticAntiviral Therapy, 2005
- Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, RussiaJournal of General Virology, 2001
- Duration of viraemia and faecal viral excretion in acute hepatitis EThe Lancet, 2000